Eczema can be very challenging to deal with, especially in the winter. The cold, dry air can exacerbate symptoms, leading to ...

Living with eczema is more than just occasional flare-ups. It’s an ongoing struggle with relentless itching, redness, and ...

AnaptysBio will end the development of its experimental drug to treat eczema as the treatment failed to meet the goals of a ...

You only want the best when it comes to skin products for your baby, and that's especially true when your little one has ...

Researchers believe they’ve discovered the hidden culprit behind eczema itch, paving the way for groundbreaking new treatment ...

Eczema-prone skin needn't mean a mundane moisturiser; our edit includes the ingredient-led, the fragranced and the luxurious ...

When conventional treatments for moderate to severe atopic dermatitis become less effective, targeted therapies may help.

Q32 Bio still sees potential for its anti-IL-7R antibody as an alopecia treatment despite failing a phase 2 eczema study—but ...

Brave Rebecca Ebbage, 31, began breaking out in painful weeping sores when she suddenly stopped using the steroid cream she ...

Health Minister Mark Butler has struck a deal to secure the place of a “life-changing” eczema treatment on the Pharmaceutical ...

AnaptysBio, Inc. (NASDAQ:ANAB) announced that investigational ANB032, a BTLA agonist, did not meet the primary and secondary ...

Chronic exposure to irritants, allergens, and repetitive hand washing are established risk factors for chronic hand eczema.